CellWell record HH-0645
Ganoderma lucidum (reishi) cancer evidence, Cochrane review
Cochrane
Cochrane Database of Systematic Reviews ยท 2016
In plain language
A Cochrane review rated the evidence for Ganoderma lucidum (reishi) in cancer treatment as low to very low quality.
- Design
- Systematic review
Cite this record: https://thecellwell.org/studies/HH-0645
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.